Artificial tumor model suitable for monitoring 31P and 13C NMR spectroscopic changes during chemotherapy-induced apoptosis in human glioma cells.
An artificial tumor method was developed to study cells inside the sensitive volume of an NMR spectrometer during growth and apoptosis. The tumor was composed of a 50:50 mixture of tightly packed porous-collagen and nonporous-polystyrene microspheres. The porous collagen served as a growth surface for the tumor cells, and the nonporous polystyrene served as a structural support to limit compression of the packed bed during perfusion. The microspheres were held between two porous polyethylene discs that were tightly sealed inside the NMR perfusion chamber. The new method was evaluated with two cell types: a mouse mammary tumor line (EMT6/SF) and a human glioma line (SF188). The results indicate that for both lines, approximately 10(9) metabolically active cells could be sustained for at least 1 week in the 12-cm(3) artificial tumor. Further, cells undergoing chemotherapy-induced apoptosis (which is known to cause detachment of cells from their surroundings) were retained in the artificial tumor. In preliminary 31P NMR studies, glioma cells treated with temozolomide (TMZ) exhibited reduced phosphocholine (PCh) levels relative to glycerophosphocholine (GPC) and diphosphodiester (DPDE) levels. They also exhibited sharply reduced oxygen consumption and TCA cycle 13C labeling, while they retained glycolytic activity. These metabolic changes are consistent with those that would be expected during mitochondrially-mediated apoptosis.
Mancuso
Anthony
A
Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6021, USA. mancusoa@uphs.upenn.edu
Zhu
Aizhi
A
Beardsley
Nancy J
NJ
Glickson
Jerry D
JD
Wehrli
Suzanne
S
Pickup
Stephen
S
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D017209:Apoptosis / Q000187:drug effects*; D014408:Biomarkers, Tumor / Q000032:analysis / Q000378:metabolism*; D002247:Carbon Isotopes; D045744:Cell Line, Tumor; D003606:Dacarbazine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D004195:Disease Models, Animal; D005910:Glioma / Q000378:metabolism*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism*; D051379:Mice; D010759:Phosphorus Isotopes; D000077204:Temozolomide
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D002247:Carbon Isotopes; D010759:Phosphorus Isotopes; D003606:Dacarbazine; D000077204:Temozolomide